AeroVironment Just Delivered Historic Results. Wall Street Says It's a Buy

AeroVironment reported fiscal 2027 Q1 revenue of $480.5 million, up 6% year over year and above the $456.1 million consensus, while adjusted EPS surged 84% to $0.59 versus $0.25 expected. Autonomous systems revenue rose 21% to $346 million, bookings jumped 71% to $683 million, and funded backlog reached a record $1.5 billion, up 37% year over year. The company maintained FY2027 revenue guidance of $2.125 billion-$2.225 billion, though midpoint adjusted EPS guidance of $3.16 implies a 4% decline due to facility expansion and higher depreciation.

Analysis

AVAV's beat matters less for the reported quarter than for evidence that autonomous-systems demand can absorb execution disruptions elsewhere in the portfolio. The mix shift toward drones raises the probability that revenue growth outpaces the current full-year plan over the next 1-3 quarters, but capacity investment means incremental revenue will not translate cleanly into EPS; investors should underwrite backlog conversion and gross-margin progression, not headline bookings. The key read-through is favorable for small unmanned systems and counter-UAS exposure, including KTOS and RCAT, while larger primes such as LMT, NOC and RTX are less sensitive but potential channel partners as directed-energy programs move from development to production.

The $1.4B of unfunded backlog is not equivalent to contracted revenue and creates an underappreciated appropriations/continuing-resolution risk in the next 30-90 days. International counter-drone demand diversifies the customer base but introduces export-license, delivery-acceptance and working-capital risk; a single delayed award can materially affect a company of AVAV's scale. The prior accounting disruption also warrants a higher discount rate until at least two clean reporting cycles establish controls and cash conversion.

Consensus may be treating the lower forward multiple as a simple valuation reset, but 32x next-year earnings still requires sustained double-digit growth and a recovery in margins after expansion spending. Upside is underappreciated if laser and counter-UAS systems establish repeatable export demand, creating a higher-quality aftermarket and production revenue stream over 6-18 months; downside is sharper if the current backlog is concentrated in low-margin fixed-price programs. AVAV is a tactical long only on confirmation that funded backlog converts to operating cash flow and management holds or raises its revenue outlook.

Key Decisions for Investors

• Maintain a 1-2% tactical long AVAV for 1-3 months only after post-earnings liquidity stabilizes; target a rerating toward 38-40x next-year EPS if guidance is raised, with a stop on a guidance cut or funded backlog declining sequentially.
• Prefer a relative-value expression: long AVAV / short KTOS in equal dollar amounts for 3-6 months if AVAV's autonomous-systems bookings continue to exceed revenue. AVAV offers nearer-term backlog conversion; exit if KTOS wins a material counter-UAS award or AVAV reports negative operating cash flow without a clearly temporary working-capital explanation.
• Do not extrapolate the international directed-energy order into estimates yet. Create an alert for export approvals, follow-on awards and SCDE segment bookings; initiate incremental AVAV exposure only if these support a 6-18 month revenue runway rather than isolated development contracts.
• Monitor U.S. appropriations and any continuing resolution over the next 30-90 days. Reduce defense-small-cap exposure, including AVAV, if procurement obligation timing slips, since unfunded awards and lumpy acceptance milestones can delay revenue and compress the multiple.